Manufacturing Solutions

The foundation of our business is “The Hearth”, a 200,000+ ft2 custom-designed, cGMP facility, dedicated to AAV viral vector manufacturing. We offer end-to-end manufacturing and development services to accelerate gene therapy programs from preclinical, through clinical, and commercial manufacturing.

Request Information

Manufacturing Services

Our foundation is hope

*5,000L bioreactors available in the second half of 2022

Blaze Vector Production

Turnkey, scalable, premier research-grade AAV production

  • Our proprietary Ignition Cells™ that have a clear, well-documented history and are optimized for scalable suspension growth
  • Established process for many standard AAV serotypes
  • Upfront communication and pricing
  • Fast turnaround time

Process & Analytical Development

End-to-end capabilities from research to cGMP, reducing the need for bridging studies.

  • Experienced team able to support process development and scale up
  • In-house analytical assay development and performance to support cGMP-readiness
  • Process development to manufacture novel engineered capsids

cGMP Production

Fully disposable, closed system processing.

  • Flexible scheduling and maximization of capacity
  • Consistent process and product flow for reduction of variation
  • 50-5,000L scale. See our 5,000L bioreactor!


Our foundation is hope

Our Advanced Technologies

At Forge, our platform approach employs the triple plasmid transfection method – the industry standard method for manufacturing AAV. This method is bolstered by Forge’s proprietary technologies, our Ignition Cells™ and pEMBR™ adenovirus helper plasmid.

Ignition Cells™

  • Royalty-free license for clients
  • Clonal HEK293 mammalian suspension cell line
  • Optimized for robust transient transfection
  • Animal component free
  • Scalable production
Our foundation is hope

pEMBR™ Adenovirus Helper Plasmid

Our foundation is hope
5/5 (2 Reviews)